New hope for schizophrenia: KarXT shows promise in phase 3 trial
NCT ID NCT05919823
First seen Nov 21, 2025 · Last updated May 11, 2026 · Updated 16 times
Summary
This study tested a new drug called KarXT in 202 Chinese adults hospitalized with schizophrenia. For 5 weeks, some received KarXT and others a placebo to see if the drug reduces symptoms like hallucinations and social withdrawal. After that, everyone could take KarXT for 12 more weeks to check long-term safety and effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Mental Health Center
Hefei, Anhui, 230022, China
-
Beijing Anding Hospital Capital Medical University
Beijing, Beijing Municipality, 100035, China
-
Beijing HuiLongGuan Hospital
Changping, Beijing Municipality, 100096, China
-
Chongqing 11th People's Hospital
Chongqing, Chongqing Municipality, 400047, China
-
Chongqing Mental Health Center
Jiangbei, Chongqing Municipality, 401147, China
-
Daqing City Third Hospital
Daqing, Heilongjiang, 163161, China
-
Guangyuan Mental Health Center
Guangyuan, Sichuan, 628033, China
-
Hangzhou Seventh People's Hospital
Hangzhou, Zhejiang, 310013, China
-
HuZhou Third Municipal Hospital
Huzhou, Zhejiang, 313028, China
-
Jiangxi Mental Health Center
Nanchang, Jiangxi, 330027, China
-
Mental Health Center of Xi'an City
Xi'an, Shaanxi, 710061, China
-
Ningbo Kangning Hospital
Ningbo, Zhejiang, 315002, China
-
Peking University Sixth Hospital
Beijing, Beijing Municipality, 100083, China
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430064, China
-
Shandong Daizhuang Hospital
Jining, Shandong, 272009, China
-
Shandong Mental Health Center
Jinan, Shandong, 250014, China
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200032, China
-
The Affiliated Brain Hospital of Guangzhou Medical University
Guanzhou, Guangdong, 510370, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325015, China
-
The Fourth People's Hospital of Chengdu
Chengdu, Sichuan, 610036, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
The Sixth People's Hosptial of Hebei Province
Baoding, Hebei, 071051, China
-
Tianjin Anding Hospital
Tianjin, Tianjin Municipality, 300382, China
-
Urumqi Fourth People's Hospital
Ürümqi, Xinjiang, 830002, China
-
Wuhan Mental Health Center
Wuhan, Hubei, 430000, China
-
Wuhu Hospital of Beijing Anding Hospital
Wuhu, Anhui, 241000, China
-
Wuxi Mental Health Center
Wuxi, Jiangsu, 214151, China
-
Zhumadian Second People's Hospital
Zhumadian, Henan, 463001, China
Conditions
Explore the condition pages connected to this study.